In the last financial year, massive investments have come back in both drug development as well as non-invasive therapies like neuromodulation and deep brain stimulation. Advances in modern brain imaging, neuroinformatics and animal models have been discussed at length but how can they be applied to screen and validate compounds, devices and other treatments at an early developmental stage?
MnM Conferences is organising the Neuroscience R&D Technologies Conference on 3rd & 4th December in Barcelona, Spain to help answer the important questions in neuroscience research.
This content is blocked. Accept cookies to view the content.